Article
Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Gastroenterology - 1 Dec 2015
Zhao Junjie, Bulek Katarzyna, Gulen Muhammet F, Zepp Jarod A, Karagkounis Georgio, Martin Bradley N, Zhou Hao, Yu Minjia, Liu Xiuli, Huang Emina, Fox Paul L, Kalady Matthew F, Markowitz Sanford D, Li Xiaoxia
Abstract excerpt
BACKGROUND & AIMS: Single immunoglobulin and toll-interleukin 1 receptor (SIGIRR), a negative regulator of the Toll-like and interleukin-1 receptor (IL-1R) signaling pathways, controls intestinal inflammation and suppresses colon tumorigenesis in mice. However, the importance of SIGIRR in human colorectal cancer development has not been determined. We investigated the role of SIGIRR in development of human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
